Adlai Nortye (ADR)
Develops clinical-stage cancer therapies targeting RAS pathways and immune responses.
$13.82
After-hours close+0.08 (+0.58%)
At close$13.74(−4.05%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 21.83%11.59M sharesInsiders 33.16%17.60M sharesOther 45.01%23.89M shares
Shares outstanding 53.08M · Float —
Float — provider float and free-float percent disagree.
The provider's float, free-float percent and share count do not reconcile, so the float is not shown.
Institutions13F, as of Mar 31, 2026
26 holders · 11.59M shares · 23 new positions · 25 increased · 0 reduced · 1 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| VR Adviser, LLC | 3.21M | 6.05% | +3.21Mnew | May 15, 2026 |
| Cormorant Asset Management, LP | 2.90M | 5.46% | +2.90Mnew | May 15, 2026 |
| Squadron Capital Management LLC | 1.27M | 2.38% | +1.27Mnew | May 15, 2026 |
| Balyasny Asset Management L.P. | 877.8K | 1.65% | +877.8Knew | May 15, 2026 |
| Millennium Management LLC | 681.8K | 1.28% | +681.8Knew | May 15, 2026 |
| Adage Capital Partners GP, L.L.C. | 538.5K | 1.01% | +538.5Knew | May 15, 2026 |
| Casdin Capital, LLC | 538.5K | 1.01% | +538.5Knew | May 15, 2026 |
| Superstring Capital Management LP | 414.9K | 0.78% | +414.9Knew | May 14, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| ANL Talent Limited | 7.75% | 9.30M | 13G | Jan 16, 2026 ↗ |
| Venrock Healthcare Capital Partners III, L.P. | 6.10% | 9.64M | 13G | Feb 11, 2026 ↗ |
| Cormorant Asset Management, LP | 5.19% | 2.90M | 13G | May 15, 2026 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Yang Lu | director, 10 percent owner, officer: CEO | 17.09M | 32.20% | May 21, 2026 |
| Lars Erik Birgerson | director | 166.7K | 0.31% | Aug 4, 2026 |
| Xiaofeng Ye | officer: CFO | 147.8K | 0.28% | Aug 26, 2026 |
| Ping Ji | director | 136.7K | 0.26% | Jun 10, 2026 |
| Archie Tse | officer: President, Head of R&D | 50.0K | 0.09% | May 20, 2026 |
| Roger Sawhney | director | 9.8K | 0.02% | Jul 15, 2026 |
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Aug 26, 2026 | Xiaofeng Yeofficer: CFO | Sale | 5,667 | $14.25 | 147,757 |
| Aug 24, 2026 | Xiaofeng Yeofficer: CFO | Sale | 6,000 | $13.98 | 153,424 |
| May 13, 2026 | Yang Ludirector, 10 percent owner, officer: CEO | Sale | 10 | $13.18 | 99,990 |
CongressHouse and Senate disclosures
Not reported.